Search Press releases Keywords From To 5 Jan 2009 UCB receives Complete Response Letter from U.S. FDA for use of Cimzia® in rheumatoid arthritis patients Read More 19 Dec 2008 UCB receives U.S. FDA Complete Response Letter for Neupro® in Restless Legs Syndrome and Advanced Parkinson's disease Read More 2 Dec 2008 UCB announces start of Phase I study for antibody drug candidate CDP6038 Read More 20 Nov 2008 Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate in Fibromyalgia Read More 18 Nov 2008 Cimzia® studies show significant clinical benefits for mono- and combination therapy in patients with rheumatoid arthritis Read More 31 Oct 2008 Transparency Notification Of UCB's Reference Shareholders Read More Pagination First page Previous page Previous … Page 166 Page 167 Page 168 Page 169 Current page 170 Page 171 Page 172 Page 173 Page 174 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
